Top worldwide anti-rheumatics by market share 2017 and 2024

The data displays the top anti-rheumatic products worldwide by market share in 2017 and a projection for 2024. Enbrel had a market share of 14.8% in 2017 which is expected to decrease to 7.2% in 2024. Anti-rheumatic drugs are used to treat and slow the progress of rheumatoid arthritis. Rheumatoid arthritis is an autoimmune disease that principally attacks the joints but also impacts tissues and organs.